|

TC-G203 cells treatment Clinical Trials

1 actively recruiting trial

Also known as: Cyclophosphamide, Fludarabine

Pipeline

Early 1: 1

Top Sponsors

  • Beijing GoBroad Hospital1

Indications

  • GPC3 Positive Hepatocellular Carcinoma1
  • Solid Cancer1
  • Cancer1

Other1 trial

TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.